日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Detection rate for ESR1 mutations is higher in circulating-tumor-cell-derived genomic DNA than in paired plasma cell-free DNA samples as revealed by ddPCR

ddPCR结果显示,循环肿瘤细胞来源的基因组DNA中ESR1突变的检出率高于配对的血浆游离DNA样本。

Smilkou, Stavroula; Ntzifa, Aliki; Tserpeli, Victoria; Balgkouranidou, Ioanna; Papatheodoridi, Alkistis; Razis, Evangelia; Linardou, Helena; Papadimitriou, Christos; Psyrri, Amanda; Zagouri, Flora; Kakolyris, Stylianos; Lianidou, Evi

Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment

对接受二线奥希替尼治疗的非小细胞肺癌患者进行全面的液体活检分析监测

Ntzifa, Aliki; Marras, Theodoros; Kallergi, Galatea; Kotsakis, Athanasios; Georgoulias, Vasilis; Lianidou, Evi

Multiplex detection of ten ESR1 mutations and AKT1 E17K in breast cancer using digital PCR

利用数字PCR技术对乳腺癌中的十种ESR1突变和AKT1 E17K进行多重检测

Smilkou, Stavroula; Ntzifa, Aliki; Stergiopoulou, Dimitra; Georgoulias, Vasilis; Lianidou, Evi

PD-L1/pS6 in Circulating Tumor Cells (CTCs) during Osimertinib Treatment in Patients with Non-Small Cell Lung Cancer (NSCLC).

非小细胞肺癌 (NSCLC) 患者接受奥希替尼治疗期间循环肿瘤细胞 (CTC) 中的 PD-L1/pS6

Pantazaka Evangelia, Ntzifa Aliki, Roumeliotou Argyro, Lianidou Evi, Georgoulias Vassilis, Kotsakis Athanasios, Kallergi Galatea

Androgen Receptor and PIM1 Expression in Tumor Tissue of Patients With Triple-negative Breast Cancer

三阴性乳腺癌患者肿瘤组织中雄激素受体和PIM1的表达

Ntzifa, Aliki; Strati, Areti; Koliou, Georgia-Angeliki; Zagouri, Flora; Pectasides, Dimitrios; Pentheroudakis, George; Christodoulou, Christos; Gogas, Helen; Magkou, Christina; Petraki, Constantina; Kosmidis, Paris; Aravantinos, Gerasimos; Kotoula, Vassiliki; Fountzilas, George; Lianidou, Evi